GBLIL Chart
- 52-Week Range: $24.55 - $26.27
- Market Capitalization: $448.31M
- Short Percentage: 0%
- Target Price: $0.00
- Shares Outstanding: 0
- Next Earnings: Nov 30
Catalysts
CategoryCatalyst
No upcoming catalysts found
News and Press Releases
- Standard BioTools Inc. (LAB) CEO Michael Egholm on Q2 2022 Results - Earnings Call TranscriptSeeking Alpha | August 8th
- Clover Health stock drops after mixed earnings, announcement of impending CEO changeMarket Watch | August 8th
- Clover Health Announces Evolution of Leadership Roles to Best Support Future GrowthGlobeNewsWire | August 8th
- Standard BioTools Announces Second Quarter 2022 Financial Results and Provides Strategic UpdateGlobeNewsWire | August 8th
- AvidXchange Offers a Complete Purchase to Pay Solution Purpose-Built for the Construction IndustryGlobeNewsWire | August 8th
- CentralSquare, NextNav Partner to Bring Z-axis Vertical Location to Public Safety Agencies NationwideBusiness Wire | August 8th
- Longeveron to Announce Second Quarter 2022 Financial Results on August 12, 2022GlobeNewsWire | August 8th
We searched over 50 sources and couldn't find any news or press releases related to Global Indemnity Limited SUB NT 47.
$GBLIL i like the stock
$GBLIL get over the hump
$GBLIL Sleep well my bulls
sleep well
$GBLIL time to short this
$GBLIL nice day!
$GBLIL Longs will be rewarded handsomely
$GBLIL recovery hasn’t even started yet.. imo
$GBLIL just added more
$GBLIL green is good
$GBLIL flow comin